Medtronic is increasing in-office work requirements to at least four days per week for employees in the United States who ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Medical-device maker Medtronic plans to separate its diabetes business into a stand-alone company, the company said, in a ...

Medtronic upgraded to 'Strong Buy' with $104 fair value. Diabetes spin-off boosts focus on core markets, driving growth, ...

While some analysts questioned why Medtronic would leave a fast-growing market, others backed the company’s plan to focus on ...

Medtronic anticipates the separation of its diabetes business unit into a wholly separate entity to complete within 18 months ...

Medtronic expects Trump administration tariffs and reciprocal tariffs from other countries to cost it $200–350 million over ...

Global medical device company Medtronic announced Wednesday that it intends to separate its diabetes business into a ...

Medtronic plans to separate from its diabetes business and launch it as an independent company—one that will count more than ...

Medical device maker Medtronic said on Wednesday it plans to separate its diabetes business, which houses its insulin pumps ...

Medtronic's stock has shown a favorable one-day return following its earnings announcements in 53% of instances.

The medical device giant, which is domiciled in Dublin, Ireland but has its main office in Fridley, Minnesota, confirmed that ...